major glp 1 drugs GLP-1 Receptor Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care GLP-1 Drug Savings: A Complete
Description
^up to 6 weeks from diagnosis
Doses for type 2 diabetes can vary from 2.5 mg weekly up to 15 mg, although high doses are generally uncommon
The company's CT-388 dual agonist and CT-996 oral formulation are progressing through Phase II trials, with potential market entry expected by 2029
Bojsen-Mller Kirstine, N
10.1016/S0140-6736(21)00213-0 18 Del PratoS.E KahnS.PavoI.WeerakkodyG
N Engl J Med 387(3):205216 Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M et al (2015) A randomized, controlled trial of 3.0 mg of liraglutide in weight management
